Balazs Sarkadi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Balazs sarkadi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Balazs Sarkadi Today - Breaking & Trending Today

Chinese Covid-19 Sinopharm vaccine offers poor protection among elderly, finds study


Chinese Covid-19 Sinopharm vaccine offers poor protection among elderly, finds study
Associated Press
Chinese, Covid-19, Sinopharm vaccine, poor protection, elderly
A new study suggests that a Sinopharm vaccine offers poor protection from Covid-19 among the elderly, raising questions for dozens of countries that have given the Chinese company s shots to their most vulnerable populations.
A survey of blood samples taken from 450 people in Hungary at least two weeks after their second Sinopharm dose found that 90 per cent under 50 years old developed protective antibodies. But the percentage declined with age, and 50 per cent of those over 80 had none.
The study by two Hungarian researchers was posted online this week but not yet reviewed by other scientists. Three outside experts said they had no problems with the methodology of the study of the vaccine developed by Sinopharm s Beijing Institute of Biological Products. ....

Hong Kong , United Arab Emirates , Tamas Ferenci , Wang Chenguang , Balazs Sarkadi , Minster Viktor Orban , Beata Englohner , Jin Dong Yan , Union Medical College , Sinopharm Beijing Institute Of Biological Products , National Health Commission , China National Health Commission , Institute Sinopharm , Global Alliance For Vaccines , Hong Kong University , Beijing Institute , Peking Union Medical College , World Health Organization , Prime Minster Viktor Orban , Beijing Institute Sinopharm , Global Alliance , ஹாங் காங் , ஒன்றுபட்டது அரபு அமீரகங்கள் , மினிஸ்டர் விக்டர் ஓர்பான் , ஜின் டாங் யான் , தொழிற்சங்கம் மருத்துவ கல்லூரி ,

China's Sinopharm Covid Vaccine Offers Poor Protection To Elderly: Study


China’s Sinopharm Covid Vaccine Offers Poor Protection To Elderly: Study
A survey of blood samples taken from 450 people in Hungary at least two weeks after their second Sinopharm dose found that 50% people over 80 hadn’t developed any antibodies.
Associated Press (AP)
24 July 2021, Last Updated at 7:07 am
Representational Image/ Unsplash
Associated Press (AP)
2021-07-24T00:40:28+05:30
China’s Sinopharm Covid Vaccine Offers Poor Protection To Elderly: Study
outlookindia.com
2021-07-24T07:07:59+05:30
Also read
A new study suggests that the Sinopharm vaccine offers poor protection from COVID-19 among the elderly, raising questions for dozens of countries that have given the Chinese company s shots to their most vulnerable populations. ....

Hong Kong , United Arab Emirates , Tamas Ferenci , Wang Chenguang , Balazs Sarkadi , Minster Viktor Orban , Beata Englohner , Jin Dong Yan , Union Medical College , Sinopharm Beijing Institute Of Biological Products , National Health Commission , China National Health Commission , Institute Sinopharm , Global Alliance For Vaccines , Hong Kong University , Beijing Institute , Peking Union Medical College , World Health Organisation , Prime Minster Viktor Orban , Beijing Institute Sinopharm , Global Alliance , ஹாங் காங் , ஒன்றுபட்டது அரபு அமீரகங்கள் , மினிஸ்டர் விக்டர் ஓர்பான் , ஜின் டாங் யான் , தொழிற்சங்கம் மருத்துவ கல்லூரி ,